-
- 伊藤 隆
- 労働者健康福祉機構鹿島労災病院和漢診療センター
書誌事項
- タイトル別名
-
- The Role of Kampo Medicine in the Age of Inhaled Steroids
- キュウニュウ ステロイドヤク ジダイ ノ カンポウ チリョウ ノ ヤクワリ
この論文をさがす
説明
With the world standardization of inhaled steroids for bronchial asthma, the principle of Kampo medicine has changed from treatment for asthma attack to the prevention of it. The number of severe adult patient cases has decreased, and the number of hojinzai (kidney tonic) users has increased. The number of weaker children has increased, and the number of hohizai (spleen tonic) users has increased. Kampo medicine was not equal to inhaled steroids for the treatment of bronchial asthma, because the number of patients treated with Kampo medicine, having more than one year without an attack, was only 10% to 20%, and this figure would be lower, with inhaled steroids.<br>Nevertheless, Kampo medicine has had a great effect, on patients with milder symptoms, who do not require inhaled steroids, and well as those patients uncontrollable even with inhaled steroids. The Saiboku-to and Maozai groups, including Sho-sei-ryu-to and Ma-kyo-kan-seki-to, are good for milder patients. It is advisable to first check the immediate reaction of Maozai group users, following its administration in the clinic for treating attacks. The Hojinzai group, including Hachimi-jio-gan and Bakumi-jio-gan-ryo, are good for patients with the severe asthma or chronic obstructive pulmonary disease. An increase in the peak-flow rate of these patients with Hachimi-jio-gan might be related to activation of dehydroepiandrosterone, although the mechanism is unknown. Moku-boi-to is indicated for those patients with complicated heart failure.
収録刊行物
-
- 日本東洋医学雑誌
-
日本東洋医学雑誌 55 (4), 447-453, 2004
一般社団法人 日本東洋医学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204908802176
-
- NII論文ID
- 110003988640
-
- NII書誌ID
- AN00015774
-
- ISSN
- 1882756X
- 02874857
-
- NDL書誌ID
- 7047699
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可